Tryptase, a novel angiogenic factor stored in mast cell granules

Experimental Cell Research

Volumn 332, Issue 2, 2015, Pages 157-162

  Ribatti, Domenico ^a,b   Ranieri, Girolamo ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Angiogenesis; Anti angiogenesis; Mast cell; Tryptase; Tumor growth

Indexed keywords

GABEXATE MESILATE; NAFAMSTAT MESILATE; TRYPTASE; TRYPTASE INHIBITOR; ANGIOGENESIS INHIBITOR; ANGIOGENIC PROTEIN;

ALLERGIC ASTHMA; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL GRANULE; HUMAN; INFLAMMATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SECRETORY GRANULE; TUMOR MICROENVIRONMENT; VASCULARIZATION; ANIMAL; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; MOLECULARLY TARGETED THERAPY; NEOPLASMS; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY;

ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ANIMALS; CYTOPLASMIC GRANULES; HUMANS; MAST CELLS; MOLECULAR TARGETED THERAPY; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TRYPTASES;

EID: 84924608669     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.11.014     Document Type: Review

References (59)

1. Trivedi N.N., Caughey G.H. Mast cell peptidases: chameleons of innate immunity and host defense. Am. J. Respir. Cell. Mol. Biol. 2010, 42:257-267.
2. Glenner G.G., Cohen L.A. Histochemical demonstration of a species-specific trypsin-like enzyme in mast cells. Nature 1960, 185:846-847.
3. Hallgren J., Pejler G. Biology of mast cell tryptase. An inflammatory mediator. FEBS J. 2006, 273:1871-1895.
4. Schwartz L.B. Tryptase: a clinical indicator of mast cell-dependent events. Allergy Asthma Proc 1994, 15:119-123.
5. Irani A.A., Schechter N.M., Craig S.S., DeBlois G., Schwartz L.B. Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA 1986, 83:4464-4468.
6. Irani A.M., Schwartz L.B. Human mast cell heterogeneity. Allergy Asthma Proc. 1994, 15:303-308.
7. Schwartz L.B., Metcalfe D.D., Miller J.S., Earl H., Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N. Engl. J. Med. 1987, 316:1622-1626.
8. Ruoss S.J., Hartmann T., Caughey G.H. Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 1991, 88:493-499.
9. Thabrew H. Mast cell tryptase is a growth factor for human airway smooth muscle. J. Allergy Clin. Immunol. 1996, 97:969.
10. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., Pavord I.D. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 2002, 346:1699-1705.
11. Huang C., De Sanctis G.T., O'Brien P.J., Mizgerd J.P., Friends D.S., Drazen J.M., Brass L.F., Stevens R.L. Evaluation of the substrate specificity of human mast cell tryptase beta I and demosntration of its importance in bacterial infections of the lung. J. Biol. Chem. 2001, 276:26276-26284.
12. Thakurdas S.M., Melicoff E., Sansores-Garcia L., Moreira D.C., Petrova Y., Stevens R.L., Adachi R. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J. Biol. Chem. 2007, 282:20809-20815.
13. Ribatti D., Crivellato E. Immune cells and angiogenesis. J. Cell Mol. Med. 2009, 13:2822-2833.
14. Ribatti D., Crivellato E. The controversial role of mast cells in tumor growth. Int. Rev. Cell. Mol. Biol. 2009, 275:89-8131.
15. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
16. Ribatti D., Crivellato E., Candussio L., Nico B., Vacca A., Roncali L., Dammacco F. Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin. Exp. Allergy: J. Br. Soc. Allergy Clin. Immunol. 2001, 31:602-608.
17. Detoraki A., Staiano R.I., Granata F., Giannattasio G., Prevete N., de Paulis A., Ribatti D., Genovese A., Triggiani M., Marone G. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects. J. Allergy Clin. Immunol. 2009, 123:1142-1149.
18. Norrby K., Jakobsson A., Sorbo J. Mast-cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1986, 52:195-206.
19. Heissig B., Rafii S., Akiyama H., Ohki Y., Sato Y., Rafael T., Zhu Z., Hicklin D.J., Okumura K., Ogawa H., Werb Z., Hattori K. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J. Exp. Med. 2005, 202:739-750.
20. Taipale J., Lohi J., Saarinen J., Kovanen P.T., Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 1995, 270:4689-4696.
21. Gruber B.L., Marchese M.J., Suzuki K., Schwartz L.B., Okada Y., Nagase H., Ramamurthy N.S. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J. Clin. Invest. 1989, 84:1657-1662.
22. Stack M.S., Johnson D.A. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J. Biol. Chem. 1994, 269:9416-9419.
23. Blair R.J., Meng H., Marchese M.J., Ren S., Schwartz L.B., Tonnesen M.G., Gruber B.L. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J. Clin. Investig. 1997, 99:2691-2700.
24. Compton S.J., Cairns J.A., Holgate S.T., Walls A.F. Human mast cell tryptase stimulates the release of an IL-8-dependent neutrophil chemotactic activity from human umbilical vein endothelial cells (HUVEC). Clin. Exp. Immunol. 2000, 121:31-36.
25. Johnson J.L., Jackson C.L., Angelini G.D., George S.J. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 1998, 18:1707-1715.
26. Ribatti D., Ranieri G., Nico B., Benagiano V., Crivellato E. Tryptase and chymase are angiogenic in vivo in the chorioallantoic membrane assay. Int. J. Dev. Biol. 2011, 55:99-102.
27. Zhi X., Xu C., Zhang H., Tian D., Li X., Ning Y., Yin L. Tryptase promotes atherosclerotic plaque haemorrhage in ApoE-/- mice. PLoS One 2013, 8.
28. Ribatti D., Ennas M.G., Vacca A., Ferreli F., Nico B., Orru S., Sirigu P. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur. J. Clin. Investig. 2003, 33:420-425.
29. Ribatti D., Vacca A., Ria R., Marzullo A., Nico B., Filotico R., Roncali L., Dammacco F. Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur. J. Cancer 2003, 39:666-674.
30. Benitez-Bribiesca L., Wong A., Utrera D., Castellanos E. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J. Histochem. Cytochem. 2001, 49:1061-1062.
31. Ribatti D., Finato N., Crivellato E., Marzullo A., Mangieri D., Nico B., Vacca A., Beltrami C.A. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am. J. Obstet. Gynecol. 2005, 193:1961-1965.
32. Marech I., Ammendola M., Sacco R., Capriuolo G.S., Patruno R., Rubini R., Luposella M., Zuccalà V., Savino E., Gadaleta C.D., Ribatti D., Ranieri G. Serum tryptase, mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients: possible translational significance. BMC Cancer 2014, 14:534.
33. Ribatti D., Finato N., Crivellato E., Guidolin D., Longo V., Mangieri D., Nico B., Vacca A., Beltrami C.A. Angiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastases. Histopathology 2007, 51:837-842.
34. Ribatti D., Belloni A.S., Nico B., Salà G., Longo V., Mangieri D., Crivellato E., Nussdorfer G.G. Tryptase- and leptin-positive mast cells correlate with vascular density in uterine leiomyomas. Am. J. Obstet. Gynecol. 2007, 196:1-7.
35. Ammendola M., Sacco R., Sammarco G., Donato G., Zuccalà V., Romano R., Luposella M., Patruno R., Vallicelli C., Verdecchia G.M., Cavaliere D., Montemurro S., Ranieri G. Mast Cells Positive to tryptase and c-Kit Receptor expressing cells correlates with angiogenesis in gastric cancer patients surgically treated. Gastroenterol. Res. Pract. 2013, 703163.
36. Ribatti D., Guidolin D., Marzullo A., Nico B., Annese T., Benagiano V., Crivellato E. Mast cells and angiogenesis in gastric carcinoma. Int. J. Exp. Pathol. 2010, 91:350-356.
37. Gulubova M., Vlaykova T. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. J. Gastroenterol. Hepatol. 2009, 24:1265-1275.
38. Acikalin M.F., Oner U., Topcu I., Yasar B., Kiper H., Colak E. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Dig. Liver Dis. 2005, 37:162-169.
39. Ammendola M., Leporini C., Marech I., Gadaleta C.D., Scognamillo G., Sacco R., Sammarco G., De Sarro G., Russo E., Ranieri G. Targeting mast cells tryptase in Tumor microenvironment: a potential antiangiogenetic strategy. Biomed. Res. Int. 2014, 154702.
40. Esposito I., Menicagli M., Funel N., Bergmann F., Boggi U., Mosca F., Bevilacqua G., Campani D. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J. Clin. Pathol. 2004, 57:630-636.
41. Ribatti D., Vacca A., Marzullo A., Nico B., Ria R., Roncali L., Dammacco F. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int. J. Cancer 2000, 85:171-175.
42. Ribatti D., Vacca A., Nico B., Quondamatteo F., Ria R., Minischetti M., Marzullo A., Herken R., Roncali L., Dammacco F. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br. J. Cancer 1999, 79:451-455.
43. Ribatti D., Polimeno G., Vacca A., Marzullo A., Crivellato E., Nico B., Lucarelli G., Dammacco F. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia 2002, 16:1680-1684.
44. Ribatti D., Molica S., Vacca A., Nico B., Crivellato E., Roccaro A.M., Dammacco F. Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia 2003, 17:1428-1430.
45. Molica S., Vacca A., Crivellato E., Cuneo A., Ribatti D. Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia. Eur. J. Haematol. 2003, 71:137-139.
46. Cabanillas-Saez A., Schalper J.A., Nicovani S.M., Rudolph M.I. Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix. Int. J. Gynecol. Cancer 2002, 12:92-98.
47. Wilk M., Liszka L., Palen P., Gabriel A., Laudanski P. Intensity of angiogenesis and mast cell infiltration in cervical intraepithelial and invasive lesions - are they correlated?. Pathol. Res. Pract. 2010, 206:217-222.
48. Carlini M.J., Dalurzo M.C.L., Lastiri J.M., Smith D.E., Vasallo B.C., Puricelli L.I., Lauria de Cidre L.S. Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance. Hum. Pathol. 2010, 41:697-705.
49. Ibaraki T., Muramatsu M., Takai S., Jin D., Maruyama H., Orino T., Katsumata T., Miyazaki M. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 2005, 28:617-621.
50. de Souza D.A., Toso V.D., Campos M.R., Lara V.S., Oliver C., Jamur M.C. Expression of mast cell proteases correlates with mast cell maturation and angiogenesis during tumor progression. PLoS One 2012, 7:e40790.
51. Ammendola M., Sacco R., Sammarco G., Donato G., Montemurro S., Ruggieri E., Patruno R., Marech I., Cariello M., Vacca A., Gadaleta C.D., Ranieri G. Correlation between serum tryptase, mast cells positive to tryptase and microvascular density in colo-rectal cancer patients: possible biological-clinical significance. PLoS One 2014, 9.
52. Goffredo V., Gadaleta C.D., Laterza A., Vacca A., Ranieri G. Tryptase serum levels in patients suffering from hepatocellular carcinoma undergoing intra-arterial chemoembolization: Possible predictive role of response to treatment. Mol. Clin. Oncol. 2013, 1:385-389.
53. Clark J.M., Abraham W.M., Fishman C.E., Forteza R., Ahmed A., Cortes A., Warne R.L., Moore W.R., Tanaka R.D. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am. J. Respir. Crit. Care Med. 1995, 152:2076-2083.
54. Erba F., Fiorucci L., Pascarella S., Menegatti E., Ascenzi P., Ascoli F. Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug. Biochem. Pharmacol. 2001, 61:271-276.
55. Mori S., Itoh Y., Shinohata R., Sendo T., Oishi R., Nishibori M. Nafamostat mesilate is an extremely potent inhibitor of human tryptase. J. Pharmacol. Sci. 2003, 92:420-423.
56. Uchima Y., Sawada T., Hirakawa K. Action of antiproteases on pancreatic cancer cells. J. Pancreas 2007, 8:479-487.
57. Yoshii M., Jikuhara A., Mori S., Iwagaki H., Takahashi H.K., Nishibori M., Tanaka N. Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners. J. Pharmacol. Sci. 2005, 98:450-458.
58. Fujiwara Y., Furukawa K., Haruki K., Shimada Y., Iida T., Shiba H., Uwagawa T., Ohashi T., Yanaga K. Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition. J. Hepatobiliary Pancreat Sci. 2011, 18:731-739.
59. Zhang S., Zeng X., Yang H., Hu G., He S. Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling. Cell Physiol. Biochem. 2012, 29:931-940.